Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

CMS New Tech Add-On Interpretation Contested By Industry Reps

This article was originally published in The Gray Sheet

Executive Summary

Medtronic will attempt to persuade CMS that the firm's Kinetra deep-brain stimulation device marks a substantial clinical improvement over its predecessor - the dual-implant Soletra - and therefore qualifies for a new technology "add-on" payment
Advertisement

Related Content

Spine submission from Medtronic
Spine submission from Medtronic
MedPAC Urges Restraint In Granting Add-On Payments For New Technologies
MedPAC Urges Restraint In Granting Add-On Payments For New Technologies
AdvaMed, MDMA Take Issue With CMS’ New Tech Add-On Payment Policy
AdvaMed, MDMA Take Issue With CMS’ New Tech Add-On Payment Policy
Stakeholder Advice To Add-On Aspirants: Meet With CMS Prior To Approval
Stakeholder Advice To Add-On Aspirants: Meet With CMS Prior To Approval
New Tech “Add-On” Payments Sought By Hospital On Behalf Of Firms
New Tech “Add-On” Payments Sought By Hospital On Behalf Of Firms
Advertisement
UsernamePublicRestriction

Register

MT020223

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel